Boosting the reduction of the environmental impact of pharmaceutical products th...
Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.
ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmenta...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TED2021-129970B-C22
OPTIMIZACION MULTIVARIABLE DE PROCESOS CATALITICOS Y DISEÑO...
214K€
Cerrado
CTQ2010-20554
DESARROLLO DE NUEVAS ESTRATEGIAS DE EXTRACCION EN EL ANALISI...
67K€
Cerrado
PTQ-14-07028
DESARROLLO DE UN PROCESO SOSTENIBLE PARA LA OBTENCIÓN DE TRI...
51K€
Cerrado
CTM2014-52471-R
REMEDIACION ELECTROQUIMICA Y BIOLOGICA DE CONTAMINANTES EMER...
261K€
Cerrado
Descripción del proyecto
ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only the API and residues/metabolites, but other chemicals and by-products of the production process. This type of approach is essential to take into consideration the types of green manufacturing approach under consideration by the pharmaceutical industry, as evidenced by the range and scope of case studies being undertaken within ETERNAL. Specific application of our risk and life cycle assessment approaches to the ETERNAL case studies is a key element of the proposed work and will provide industry and policymakers with key examples of how whole life cycle assessment may be used to evaluate the changes in environmental impacts expected due to the introduction of green manufacturing processes.